You're building a halal portfolio and JNJ keeps coming up. It's one of the most widely held healthcare stocks in the world. Before you buy, you want to know: does it actually pass Shariah screening? The answer is yes.
Johnson & Johnson is rated Shariah-compliant by Zoya using AAOIFI guidelines. Its core business, medical products and pharmaceuticals, is permissible. Its financial ratios, including debt levels and interest income, fall within acceptable thresholds. If you're looking for a healthcare stock that checks out under Islamic screening, JNJ is one of the cleaner options out there.
Ready to compare halal options?
What is Johnson & Johnson?
Johnson & Johnson is one of the oldest and largest healthcare companies in the world. Founded in 1886 and headquartered in New Brunswick, New Jersey, the company operates two main segments: Innovative Medicine and MedTech.
Innovative Medicine covers pharmaceuticals across immunology, oncology, infectious diseases, neuroscience, and cardiovascular conditions. MedTech covers interventional cardiology, orthopaedics, surgery, and vision. One thing worth knowing: JNJ spun off its consumer health division as a separate company called Kenvue in 2023. So the JNJ you're buying today is a pure pharmaceutical and medical device company, with no more Band-Aids or Tylenol in the mix.
How Zoya screens JNJ for Shariah compliance
Zoya applies AAOIFI (Accounting and Auditing Organization for Islamic Financial Institutions) methodology, which is the most widely accepted standard for Islamic investing. The screening works in two stages.
First is the business activity screen. Zoya checks whether the company's primary operations involve anything prohibited under Islamic law, including alcohol, tobacco, conventional banking, weapons, gambling, pork, or adult entertainment. Healthcare and medical devices are permissible. JNJ clears this screen easily.
Second are the financial ratio screens. AAOIFI sets specific thresholds for debt and impure income. Debt relative to total assets must stay below 33%. Interest-bearing receivables and interest income are each capped at 5% of total revenue or assets. These screens exist because even a permissible business can become problematic if it's heavily financed through interest-bearing debt.
Why JNJ passes Shariah screening
JNJ's interest income sits at approximately 0.09% of combined revenue. That's well below the 5% AAOIFI threshold. Its debt ratios also remain within acceptable limits. For a company of this size, that's not automatic. Large multinationals often carry heavy debt loads, especially ones that fund R&D through borrowing. JNJ's balance sheet is conservatively managed by pharma industry standards.
The Kenvue spin-off in 2023 actually helped here. Consumer health products like shampoos and over-the-counter drugs brought more revenue complexity. With those gone, JNJ's remaining operations are tightly focused on prescription medicines and medical devices, both of which are straightforwardly permissible.
For Muslim investors who want exposure to the healthcare sector, JNJ is one of the few large-cap options that consistently clears AAOIFI screens. You can verify its current status in Zoya before buying, since ratings are updated quarterly.
What should Muslim investors do?
If you've been looking for halal healthcare exposure, JNJ is worth considering. Check Zoya to confirm the current compliance status before you buy. Shariah ratings can shift as a company's financials change, so looking it up takes 30 seconds and could save you from holding a stock that's slipped out of compliance.
Top Providers for This Topic
Free to compare · No sign-up required
If you want broader exposure without picking individual stocks, some halal ETFs like SPUS and HLAL hold compliant healthcare names within diversified portfolios. That's a valid approach if you prefer not to monitor individual companies each quarter.
For a deeper breakdown of what makes any stock halal, the full methodology guide on HalalWallet walks through how AAOIFI rules apply to real companies, which is worth reading before you build out a halal stock portfolio.
Bottom line
JNJ is halal. Zoya rates it Shariah-compliant under AAOIFI guidelines. The business is healthcare, which is permissible, and the financial structure is clean, with interest income at just 0.09% of revenue. If you want a large-cap, well-established stock in the healthcare space, JNJ passes the screen. Verify the current rating in Zoya before you buy, and check back quarterly.
If you're building a halal equity portfolio more broadly, the best halal stocks guide covers a range of compliant names across multiple sectors.
Frequently asked questions
Is JNJ in halal ETFs like SPUS or HLAL?
It depends on the ETF and its screening date. Some halal ETFs do include JNJ when it's compliant. Check the fund's current holdings list or look it up on Zoya to see which ETFs hold it.
Can compliance status change?
Yes. Shariah compliance is based on financial ratios that change every quarter as companies report earnings and update their balance sheets. A stock that's compliant today could fail next quarter if debt rises or interest income increases. Always verify before buying and set a reminder to check again each quarter.
What changed when JNJ spun off Kenvue?
JNJ separated its consumer health division (Band-Aid, Tylenol, Listerine, etc.) into a standalone public company called Kenvue in 2023. The remaining JNJ entity is purely pharmaceutical and medical device focused. This simplifies the halal assessment because consumer products sometimes carry more revenue complexity.
Does Zoya use AAOIFI or another standard?
Zoya uses AAOIFI guidelines, which are the most widely adopted standard for Islamic investing globally. The two main screens are the business activity screen and the financial ratio screens covering debt and interest income. You can read more about how stock screening works in the Zoya app review on HalalWallet.
Compare providers in your state
See side-by-side comparisons of Shariah-compliant products, or let our matcher recommend the best options for your situation.
How does JNJ compare to other healthcare stocks for halal investors?
JNJ is one of the more consistently compliant large-cap healthcare stocks. Pfizer, by contrast, fails AAOIFI screening due to high debt ratios. For comparison across different stocks and screening approaches, the Zoya vs Musaffa guide explains how different screening tools approach the same companies.
